Pyridine derivatives as mGluR2 antagonists
US8183262B2 · kind B2 · utility
1Cited by
6References
52Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 1, 2009 |
| Grant date | May 22, 2012 |
| Priority date | — |
| Expiry date | Sep 1, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F5/025
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula (I), a process for the manufacture thereof, pharmaceutical compositions containing them, and their use for treating CNS disorders:wherein A, B, X, Y, R1, R2, R3 and R4 are as defined in the description and claims.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.